Analysis of patients with two hereditary cancers (breast/ovarian or colon/endometrial) who met NCCN genetic testing criteria after their first cancer.

被引：0
|
作者：
Saam, Jennifer [1 ]
Moyes, Kelsey [1 ]
Arnell, Christopher [1 ]
Landon, Michelle [1 ]
Kaldate, Rajesh R. [1 ]
Strike, Brian [1 ]
Williams, Kayon [1 ]
Burbidga, Lynn Anna [1 ]
Abbott, Brian [1 ]
机构：
[1] Myriad Genet Labs Inc, Salt Lake City, UT USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2014年 / 32卷 / 15期
关键词：
D O I：
10.1200/jco.2014.32.15_suppl.1542
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1542
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Patient indications for mutation testing after referral for genetic counseling for breast/ovarian cancer.
    Nunes, M
    Fries, MH
    Murphy, KM
    Flanagan, J
    McClellan, MW
    Bartholomew, D
    AMERICAN JOURNAL OF HUMAN GENETICS, 1997, 61 (04) : A384 - A384
  • [22] First experiences with the GS Junior 454 in molecular genetic analysis of patients with hereditary breast and ovarian cancer at the Center of Familial Breast and Ovarian Cancer, Cologne
    Bluemcke, B.
    Baasner, A.
    Hauke, J.
    Wappenschmidt, B.
    Hahnen, E.
    Schmutzler, R.
    ONCOLOGY RESEARCH AND TREATMENT, 2014, 37 : 22 - 22
  • [23] Communication with close and distant relatives in the context of genetic testing for hereditary breast and ovarian cancer in cancer patients
    Claes, E
    Evers-Kiebooms, G
    Boogaerts, A
    Decruyenaere, M
    Denayer, L
    Legius, E
    AMERICAN JOURNAL OF MEDICAL GENETICS PART A, 2003, 116A (01) : 11 - 19
  • [24] Assessment of Genetic Counseling Referrals and Testing for Patients At Risk for Hereditary Breast and Ovarian Cancer Syndromes
    Smith, E.
    Kline, R.
    GYNECOLOGIC ONCOLOGY, 2016, 143 (01) : 208 - 208
  • [25] Differences Between Women Who Pursued Genetic Testing for Hereditary Breast and Ovarian Cancer and Their At-Risk Relatives Who Did Not
    Katapodi, Maria C.
    Northouse, Laurel
    Pierce, Penny
    Milliron, Kara J.
    Liu, Guipeng
    Merajver, Sofia D.
    ONCOLOGY NURSING FORUM, 2011, 38 (05) : 572 - 581
  • [26] Clinicopathologic analysis of 722 breast cancer patients who met the inclusion criteria of the TAILORx trial
    Xiang Hong-Yu
    Liu Yin-Hua
    Zhang Hong
    Zhang Shuang
    Xin Ling
    Xu Ling
    Ye Jing-Ming
    Li Ting
    Duan Xue-Ning
    Liu Qian
    中华医学杂志英文版, 2019, 132 (24) : 2914 - 2915-2916-2917-2918-2919
  • [27] Clinicopathologic analysis of 722 breast cancer patients who met the inclusion criteria of the TAILORx trial
    Xiang, Hong-Yu
    Liu, Yin-Hua
    Zhang, Hong
    Zhang, Shuang
    Xin, Ling
    Xu, Ling
    Ye, Jing-Ming
    Li, Ting
    Duan, Xue-Ning
    Liu, Qian
    CHINESE MEDICAL JOURNAL, 2019, 132 (24) : 2914 - 2919
  • [28] Impact of gene patents and licensing practices on access to genetic testing for inherited susceptibility to cancer: Comparing breast and ovarian cancers with colon cancers
    Cook-Deegan, Robert
    DeRienzo, Christopher
    Carbone, Julia
    Chandrasekharan, Subhashini
    Heaney, Christopher
    Conover, Christopher
    GENETICS IN MEDICINE, 2010, 12 (04) : S15 - S38
  • [29] A qualitative analysis of patient- and provider-perceived barriers and facilitators to cascade genetic testing for hereditary breast, ovarian, endometrial and colorectal cancer
    Stock, Elizabeth
    Walsh-Bailey, Callie
    Tuda, Daniela
    Tabak, Rachel
    Hagemann, Andrea
    GYNECOLOGIC ONCOLOGY, 2022, 166 : S213 - S213
  • [30] Multigene panel testing for hereditary breast and ovarian cancers: An analysis of 1303 BRCA-negative Chinese patients
    Kwong, Ava
    Shin, Vivian
    Au, Chun Hang
    Ho, Cecilia
    Chan, Tsun Leung
    Ma, Edmond
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
12345